Association of Hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: The role of race

Nephron - Clinical Practice

Volumn 120, Issue 1, 2012, Pages

  Hayes, John ^a   Kalantar Zadeh, Kamyar ^b   Lu, Jun L ^c   Turban, Sharon ^d   Anderson, John E ^d   Kovesdy, Csaba P ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Chronic kidney disease; Glomerular filtration rate; Mortality; Race; Serum potassium

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM;

AGED; ARTICLE; CAUCASIAN; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERKALEMIA; HYPOKALEMIA; KIDNEY FUNCTION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEGRO; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BODY MASS INDEX; CHRONIC DISEASE; COMORBIDITY; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; HYPERKALEMIA; HYPOKALEMIA; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; SMOKING; VIRGINIA;

EID: 84859320446     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000329511     Document Type: Article

References (52)

1. Gonick HC, Kleeman CR, Rubini ME, et al: Functional impairment in chronic renal disease. Studies of potassium excretion. Am J Med Sci 1971; 261: 281-290.
2. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482. (Pubitemid 20174016)
3. Iseki K, Uehara H, Nishime K, et al: Impact of the initial levels of laboratory variables on survival in chronic dialysis patients. Am J Kidney Dis 1996; 28: 541-548. (Pubitemid 26337593)
4. Einhorn LM, Zhan M, Hsu VD, et al: The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 2009; 169: 1156-1162.
5. Tannen RL: The influence of potassium on blood pressure. Kidney Int Suppl 1987; 22:S242-S248.
6. Wang W, Soltero L, Zhang P, et al: Renal inflammation is modulated by potassium in chronic kidney disease: possible role of Smad7. Am J Physiol Renal Physiol 2007; 293:F1123-F1130. (Pubitemid 47583945)
7. Oberleithner H, Callies C, Kusche-Vihrog K, et al: Potassium softens vascular endothelium and increases nitric oxide release. Proc Natl Acad Sci USA 2009; 106: 2829-2834.
8. Pere AK, Krogerus L, Mervaala EM, et al: Beneficial effects of dietary magnesium and potassium on cardiac and renal morphologic features in cyclosporin A-induced damage in spontaneously hypertensive rats. Surgery 2000; 128: 67-75. (Pubitemid 30456898)
9. Ishimitsu T, Tobian L, Sugimoto K, et al: High potassium diets reduce macrophage adherence to the vascular wall in strokeprone spontaneously hypertensive rats. J Vasc Res 1995; 32: 406-412. (Pubitemid 26036930)
10. Ishimitsu T, Tobian L, Sugimoto K, et al: High potassium diets reduce vascular and plasma lipid peroxides in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 1996; 18: 659-673. (Pubitemid 26201925)
11. Brancati FL, Appel LJ, Seidler AJ, et al: Effect of potassium supplementation on blood pressure in African Americans on a low-potassium diet. A randomized, double-blind, placebo-controlled trial. Arch Intern Med 1996; 156: 61-67. (Pubitemid 26018386)
12. Morris RC Jr, Sebastian A, Forman A, et al: Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension 1999; 33: 18-23. (Pubitemid 29061836)
13. Grim CE, Luft FC, Miller JZ, et al: Racial differences in blood pressure in Evans County, Georgia: relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis 1980; 33: 87-94. (Pubitemid 10213000)
14. Langford HG, Cushman WC, Hsu H: Chronic effect of KCl on black-white differences in plasma renin activity, aldosterone, and urinary electrolytes. Am J Hypertens 1991; 4: 399-403.
15. Luft FC, Rankin LI, Bloch R, et al: Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation 1979; 60: 697-706. (Pubitemid 9254074)
16. Wong CM, O'Connor DT, Martinez JA, et al: Diminished renal kallikrein responses to mineralocorticoid stimulation in African Americans: determinants of an intermediate phenotype for hypertension. Am J Hypertens 2003; 16: 281-289. (Pubitemid 36384755)
17. Cohen SL, Jhetam D, Da SJ, et al: Sodium and potassium status, plasma renin and aldosterone profiles in normotensive and hypertensive Johannesburg blacks. S Afr Med J 1982; 62: 941-944. (Pubitemid 13168372)
18. Easterling RE: Racial factors in the incidence and causation of end-stage renal disease (ESRD). Trans Am Soc Artif Intern Organs 1977; 23: 28-33.
19. Rostand SG, Kirk KA, Rutsky EA, et al: Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med 306; 1982: 1276-1279. (Pubitemid 12100210)
20. Kalantar-Zadeh K, Kovesdy CP, Derose SF, et al: Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol 2007; 3: 493-506. (Pubitemid 47313025)
21. Kovesdy CP, Anderson JE, Derose SF, et al: Outcomes associated with race in males with nondialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 973-978.
22. Kovesdy CP, Trivedi BK, Anderson JE: Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study. Adv Chronic Kidney Dis 2006; 13: 183-188.
23. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, et al: Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant 2006; 21: 1257-1262.
24. Levey AS, Bosch JP, Lewis JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
25. Singer JD, Willett JB: Applied Longitudinal Data Analysis. Modeling Change and Event Occurrence. Oxford, Oxford University Press, 2003.
26. Royston P, Sauerbrei W: Multivariable modeling using cubic regression splines: a principled approach. Stata J 2007; 7: 45-70.
27. Epstein FH: Signs and symptoms of electrolyte disorders; in Maxwell MH, Kleeman CR (eds): Clinical disorders of fluid and electrolyte metabolism, ed 3. New York, McGraw-Hill, 1980, p 145.
28. Fisch C: Electrolytes and the heart; in Hurst JW (ed): The Heart. New York, McGraw-Hill, 1982, p 1599.
29. Kleeman K, Singh BN: Serum electrolytes and the heart; in Maxwell MH, Kleeman CR (eds): Clinical Disorders of Fluid and Electrolyte Metabolism, ed 3. New York, Mc-Graw-Hill, 1980, p 145.
30. Turban S, Miller ER III, Ange B, et al: Racial differences in urinary potassium excretion. J Am Soc Nephrol 2008; 19: 1396-1402.
31. Aviv A, Hollenberg NK, Weder A: Urinary potassium excretion and sodium sensitivity in blacks. Hypertension 2004; 43: 707-713. (Pubitemid 38405572)
32. Urinary and serum electrolytes in untreated black and white hypertensives. Veterans Administration Cooperative Study Group on Antihypertensive Agents. J Chronic Dis 1987 40 839-847
33. Barlow RJ, Connell MA, Milne FJ: A study of 48-hour faecal and urinary electrolyte excretion in normotensive black and white South African males. J Hypertens 1986; 4: 197-200.
34. Taylor EN, Curhan GC: Differences in 24-hour urine composition between black and white women. J Am Soc Nephrol 2007; 18: 654-659. (Pubitemid 46193332)
35. Suh A, DeJesus E, Rosner K, et al: Racial differences in potassium disposal. Kidney Int 2004; 66: 1076-1081. (Pubitemid 39121012)
36. Voors AW, Dalferes ER Jr, Frank GC, et al: Relation between ingested potassium and sodium balance in young Blacks and whites. Am J Clin Nutr 1983; 37: 583-594. (Pubitemid 13057048)
37. He Q, Heo M, Heshka S, et al: Total body potassium differs by sex and race across the adult age span. Am J Clin Nutr 2003; 78: 72-77. (Pubitemid 39655250)
38. Luft FC, Grim CE, Fineberg N, et al: Effects of volume expansion and contraction in normotensive whites, blacks, and subjects of different ages. Circulation 1979; 59: 643-650. (Pubitemid 9154955)
39. Conn JW, Johnson RD: Kaliopenic nephropathy. Am J Clin Nutr 1956; 4: 523-528.
40. Elger M, Bankir L, Kriz W: Morphometric analysis of kidney hypertrophy in rats after chronic potassium depletion. Am J Physiol 1992; 262:F656-F667.
41. Torres VE, Young WF Jr, Offord KP, et al: Association of hypokalemia, aldosteronism, and renal cysts. N Engl J Med 1990; 322: 345-351. (Pubitemid 20042738)
42. Cremer W, Bock KD: Symptoms and course of chronic hypokalemic nephropathy in man. Clin Nephrol 1977; 7: 112-119. (Pubitemid 8078054)
43. Riemenschneider T, Bohle A: Morphologic aspects of low-potassium and low-sodium nephropathy. Clin Nephrol 1983; 19: 271-279. (Pubitemid 13054395)
44. Copeland PM: Renal failure associated with laxative abuse. Psychother Psychosom 1994; 62: 200-202. (Pubitemid 24322760)
45. Wright LF, DuVal JW Jr: Renal injury associated with laxative abuse. South Med J 1987; 80: 1304-1306. (Pubitemid 17160796)
46. Menahem SA, Perry GJ, Dowling J, et al: Hypokalaemia-induced acute renal failure. Nephrol Dial Transplant 1999; 4: 2216-2218. (Pubitemid 29403416)
47. Ray PE, Suga S, Liu XH, et al: Chronic potassium depletion induces renal injury, salt sensitivity, and hypertension in young rats. Kidney Int 2001; 59: 1850-1858. (Pubitemid 32336800)
48. Fryer JN, Burns KD, Ghorbani M, et al: Effect of potassium depletion on proximal tubule AT1 receptor localization in normal and remnant rat kidney. Kidney Int 2001; 60: 1792-1799. (Pubitemid 32999984)
49. Tolins JP, Hostetter MK, Hostetter TH: Hypokalemic nephropathy in the rat. Role of ammonia in chronic tubular injury. J Clin Invest 1987; 79: 1447-1458. (Pubitemid 17099649)
50. Jager KJ, Zoccali C, Macleod A, Dekker FW: Confounding: what it is and how to deal with it. Kidney Int 2008; 73: 256-260.
51. Pere AK, Lindgren L, Tuomainen P, et al: Dietary potassium and magnesium supplementation in cyclosporine-induced hypertension and nephrotoxicity. Kidney Int 2000; 58: 2462-2472.
52. Tobian L, MacNeill D, Johnson MA, et al: Potassium protection against lesions of the renal tubules, arteries, and glomeruli and nephron loss in salt-loaded hypertensive Dahl S rats. Hypertension 1984; 6:I170-I176.